Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen. (Q53251807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

lymphoproliferative disorders

28 December 2019

main subject

1 reference

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Raoul Herbrecht

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Anna Koumarianou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Cécile Fohrer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sophie Caillard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Bernard Ellero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Marie-Lorraine Woehl-Jaeglé

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Carole Meyer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Eric Epailly

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Marie-Pierre Chenard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Bruno Lioure

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Shanti Natarajan-Ame

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Frédéric Maloisel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Philippe Lutun

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Romain Kessler

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jean-Pierre Bergerat

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Philippe Wolf

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

2 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

602-612

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16889621%20AND%20SRC:MED&resulttype=core&format=json

Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Lymphoproliferative disorders after organ transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Treatment of PTLD with rituximab or chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Clinical and pathological features of posttransplant lymphoproliferative disorders: influence on survival and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Post-transplant lymphoproliferative disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Clinical characteristics of post-transplant lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X

Lymphomas occurring late after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06228.X